Bridgefront Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.37M | Buy |
+12,742
| New | +$2.37M | 0.63% | 11 |
|
|
2023
Q4 | – | Sell |
-4,757
| Closed | -$709K | – | 349 |
|
|
2023
Q3 | $709K | Sell |
4,757
-5,490
| -54% | -$818K | 0.5% | 30 |
|
|
2023
Q2 | $1.38M | Buy |
+10,247
| New | +$1.38M | 0.75% | 6 |
|
|
2023
Q1 | – | Sell |
-3,339
| Closed | -$540K | – | 405 |
|
|
2022
Q4 | $540K | Buy |
+3,339
| New | +$540K | 0.38% | 80 |
|
|
2022
Q1 | – | Sell |
-4,613
| Closed | -$625K | – | 252 |
|
|
2021
Q4 | $625K | Buy |
+4,613
| New | +$625K | 0.61% | 30 |
|
|
2021
Q3 | – | Sell |
-3,309
| Closed | -$373K | – | 298 |
|
|
2021
Q2 | $373K | Buy |
+3,309
| New | +$373K | 0.14% | 268 |
|
|
2021
Q1 | – | Sell |
-8,114
| Closed | -$869K | – | 641 |
|
|
2020
Q4 | $869K | Buy |
+8,114
| New | +$869K | 0.3% | 78 |
|